{ "market" : {"NAME" : "U.S.", "ID" : "us_market", "TZ" : "ET", "TZOFFSET" : "-18000", "open" : "1258986645", "close" : "1259010045", "flags" : {}} , "STREAMER_SERVER" : "http://streamerapi.finance.yahoo.com","arrowAsChangeSign" : false,"throttleInterval": "1000"}
globenewswire

avVaa World Health Care Products Inc. Announces Launch of Third Media Test

  • Press Release
  • Source: avVaa World Health Care Products Inc.
  • On 5:55 pm EDT, Thursday October 29, 2009

LUMBY, British Columbia, Oct. 29, 2009 (GLOBE NEWSWIRE) -- avVaa World Health Care Products Inc. (Pink Sheets:AVVH - News), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of their third Direct TV Media test today.

Related Quotes

SymbolPriceChange
AVVH.PK0.000.00
Chart for AVVAA WORLD HLTHCR
{"s" : "avvh.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}

avVaa World Health Care Products launched their third test of the Neuroskin Psoriasis Relief direct TV commercial this morning. The two minute infomercial styled commercial will run on four television stations -- two national stations and two regional.

The media test will offer Neuroskin(R) at a different price point, as well as compare running a high number of commercials on regional networks with a smaller number on national channels.

"We chose a Thursday launch since TV viewership is higher later in the week," commented Lorie Campbell-Farley, President and Chief Operating Officer. "Since we are testing the effect of frequency, we want to get as many commercials into as short a period of time as possible."

The media test will run until early next week on the regional channels CLTV and New England News Channel, and national channels THIS TV and Military Channel.

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Weblog: http://avvaaexec.com/

Facebook: http://www.facebook.com/pages/avVaa-World-Health-Care-Products/172801472320?v=wall

Twitter: https://twitter.com/avVaaWorld

Contact:

avVaa World Health Care Products Inc.
Investor Relations:
Merle Goertz (West Coast)
1-604-688-2349
info@avvaa.com

Sponsored Links

Copyright © 2009 GlobeNewswire. All rights reserved. Redistribution of this content is expressly prohibited without prior written consent. GlobeNewswire makes no claims concerning the accuracy or validity of the information, and shall not be held liable for any errors, delays, omissions or use thereof.